Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR
Détails
ID Serval
serval:BIB_A908FE3742B5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR
Périodique
European Journal of Immunology
ISSN
0014-2980 (Print)
Statut éditorial
Publié
Date de publication
04/2000
Volume
30
Numéro
4
Pages
1120-6
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Apr
Research Support, Non-U.S. Gov't --- Old month value: Apr
Résumé
The use of newly generated murine monoclonal antibodies directed against distinct epitopes of a functionally active, chemically synthesized HIV-1 Tat protein has permitted the identification of several molecular forms including monomers, dimers and trimers. Dimers and trimers are particularly stable and resistant to strong reducing conditions. Through epitope mapping it has been possible to demonstrate that the major immunodominant epitope is contained within the basic region of the Tat protein and is lost after oligomerization of the molecule. In contrast, N-terminal, C-terminal and conformation-dependent epitopes are still accessible to mAb specific recognition after Tat oligomerization. Moreover, by using a quantitative HIV-LTR transactivation assay depending upon exogenous Tat, we could extrapolate the amount of functional Tat produced by cell lines stably transfected with the viral transactivator. More importantly, we could show that only the monomeric form of exogenous Tat is the relevant functional form acting in cells harbouring the HIV-1 LTR promoter.
Mots-clé
Alkylation
Amino Acid Sequence
Antibodies, Monoclonal/*immunology/pharmacology
Antibody Specificity/immunology
Cell Line
Dimerization
Dose-Response Relationship, Drug
Epitope Mapping
Gene Expression Regulation, Viral/drug effects
Gene Products, tat/chemical synthesis/*immunology/*metabolism/pharmacology
HIV Antibodies/immunology/pharmacology
HIV Long Terminal Repeat/*genetics
HIV-1/*genetics
Heat
Humans
Immunodominant Epitopes/chemistry/immunology
Protein Binding/drug effects
Protein Conformation/drug effects
Protein Denaturation/drug effects
Reducing Agents/pharmacology
Solutions
*Trans-Activation (Genetics)/drug effects
Transfection
Pubmed
Web of science
Open Access
Oui
Création de la notice
24/01/2008 14:55
Dernière modification de la notice
20/08/2019 15:13